Gsa Capital Partners LLP Nant Health, Inc. Transaction History

Gsa Capital Partners LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$1.61 - $2.41 $263,782 - $394,854	-163,840 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$2.25 - $3.37 $207,387 - $310,619	92,172 Added 128.61%	163,840 $380,000
Q1 2021 May 10, 2021	SELL	$3.0 - $5.1 $133,953 - $227,720	-44,651 Reduced 38.39%	71,668 $230,000
Q4 2020 Feb 03, 2021	BUY	$1.96 - $3.56 $195,249 - $354,636	99,617 Added 596.44%	116,319 $376,000
Q3 2020 Nov 06, 2020	BUY	$2.1 - $5.99 $35,074 - $100,044	16,702 New	16,702 $39,000

Q4 2017 Feb 14, 2018	SELL	$2.92 - $4.97 $211,992 - $360,822	-72,600 Closed	0 $0
Q3 2017 Nov 20, 2017	BUY	$2.66 - $4.68 $193,116 - $339,768	72,600	72,600 $299,000

Ticker NH
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 115,550,000
Market Cap $48.5M
Description
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Ev...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.